Matteo Montani

Matteo Montani

Auto-generated profile, based on publicly available information

Matteo Montani

Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2023 in JHEP Reports
Verified
Journal Article
Open access
PSPatcharamon Seubnooch
Patcharamon Seubnooch
MMMatteo Montani
Matteo Montani
STSofia Tsouka
Sofia Tsouka
ECEmmanuelle Claude
Emmanuelle Claude
URUmara Rafiqi
Umara Rafiqi
Mojgan MasoodiMojgan Masoodi
Mojgan Masoodi
Lipid metabolism plays an important role in liver pathophysiology. The liver lobule asymmetrically distributes oxygen and nutrition, resulting in heterogeneous metabolic functions. Periportal and pericentral hepatocytes have different metabolic functions, which lead to generating liver zonation. We developed spatial metabolic imaging using desorption electrospray ionisation mass spectrometry to investigate lipid distribution across liver zonation with high reproducibility and accuracy. Fresh frozen livers from healthy mice with control diet were analysed using desorption electrospray ionisation mass spectrometry imaging. Imaging was performed at 50 μm × 50 μm pixel size. Regions of interest (ROIs) were manually created by co-registering with histological data to determine the spatial hepatic lipids across liver zonation. The ROIs were confirmed by double immunofluorescence. The mass list of specific ROIs was automatically created, and univariate and multivariate statistical analysis were performed to identify statistically significant lipids across liver zonation. A wide range of lipid species was identified, including fatty acids, phospholipids, triacylglycerols, diacylglycerols, ceramides, and sphingolipids. We characterised hepatic lipid signatures in three different liver zones (periportal zone, midzone, and pericentral zone) and validated the reproducibility of our method for measuring a wide range of lipids. Fatty acids were predominantly detected in the periportal region, whereas phospholipids were distributed in both the periportal and pericentral zones. Interestingly, phosphatidylinositols, PI(36:2), PI(36:3), PI(36:4), PI(38:5), and PI(40:6) were located predominantly in the midzone (zone 2). Triacylglycerols and diacylglycerols were detected mainly in the pericentral region. De novo triacylglycerol biosynthesis appeared to be the most influenced pathway across the three zones. The ability to accurately assess zone-specific hepatic lipid distribution in the liver could lead to a better understanding of lipid metabolism during the progression of liver disease. Zone-specific hepatic lipid metabolism could play an important role in lipid homoeostasis during disease progression. Herein, we defined the zone-specific references of hepatic lipid species in the three liver zones using molecular imaging. The de novo triacylglycerol biosynthesis was highlighted as the most influenced pathway across the three zones.

9 February 2014 in Swiss Medical Weekly
Verified
Journal Article
Open access
AHAdrian Thomas Huber
Adrian Thomas Huber
LELukas Ebner
Lukas Ebner
MMMatteo Montani
Matteo Montani
NSNasser Semmo
Nasser Semmo
KCKingshuk Roy Choudhury
Kingshuk Roy Choudhury
ACAndreas Christe
Andreas Christe
PRINCIPLES: Computed tomography (CT) is inferior to the fibroscan and laboratory testing in the noninvasive diagnosis of liver fibrosis. On the other hand, CT is a frequently used diagnostic tool in modern medicine. The auxiliary finding of clinically occult liver fibrosis in CT scans could result in an earlier diagnosis. The aim of this study was to analyse quantifiable direct signs of liver remodelling in CT scans to depict liver fibrosis in a precirrhotic stage. METHODS: Retrospective review of 148 abdominal CT scans (80 liver cirrhosis, 35 precirrhotic fibrosis and 33 control patients). Fibrosis and cirrhosis were histologically proven. The diameters of the three main hepatic veins were measured 1–2 cm before their aperture into the inferior caval vein. The width of the caudate and the right hepatic lobe were divided, and measured horizontally at the level of the first bifurcation of the right portal vein in axial planes (caudate-right-lobe ratio). A combination of both (sum of liver vein diameters divided by the caudate-right lobe ratio) was defined as the ld/crl ratio. These metrics were analysed for the detection of liver fibrosis and cirrhosis. RESULTS: An ld/crl-r <24 showed a sensitivity of 83% and a specificity of 76% for precirrhotic liver fibrosis. Liver cirrhosis could be detected with a sensitivity of 88% and a specificity of 82% if ld/crl-r <20. CONCLUSION: An ld/crl-r <24 justifies laboratory testing and a fibroscan. This could bring forward the diagnosis and patients would profit from early treatment in a potentially reversible stage of disease.

15 January 2019 in Gut and Liver
Verified
Journal Article
Open access
PDF file
VSViola Schlossberger
Viola Schlossberger
MWMathias Worni
Mathias Worni
CKChristina Kihm
Christina Kihm
MMMatteo Montani
Matteo Montani
CDChristian Datz
Christian Datz
FSFelix Stickel
Felix Stickel
Viola Schlossberger, Mathias Worni, Christina Kihm, Matteo Montani, Christian Datz, Jochen Hampe, and Felix Stickel. Gut and Liver 2019;13:77-82. https://doi.org/10.5009/gnl18037

26 April 2021 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
MDMaria Delgado
Maria Delgado
SCStefania Casu
Stefania Casu
MMMatteo Montani
Matteo Montani
FBFelix Brunner
Felix Brunner
NSNasser Semmo
Nasser Semmo
JDJean-François Dufour
Jean-François Dufour
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a potentially life-threatening drug reaction, which can affect multiple organs. Patients with DRESS syndrome and hepatic manifestations may present alterations ranging from mild hepatitis to acute liver failure. The diagnosis might be difficult, and the management of these patients is challenging. This report analyzes a series of five cases reporting the clinical presentation, which ranged from acute hepatitis to liver failure, and discussed their treatment.

3 April 2023
Verified
Other
Open access
SPSimone Portmann
Simone Portmann
RFRené Fahrner
René Fahrner
ALAntje Lechleiter
Antje Lechleiter
AKAdrian Keogh
Adrian Keogh
SOSarah Overney
Sarah Overney
DSDeborah Stroka
Deborah Stroka

3 April 2023
Verified
Other
Open access
SPSimone Portmann
Simone Portmann
RFRené Fahrner
René Fahrner
ALAntje Lechleiter
Antje Lechleiter
AKAdrian Keogh
Adrian Keogh
SOSarah Overney
Sarah Overney
DSDeborah Stroka
Deborah Stroka